Dr. Channa Kolb helps develop patient education material for MS drug DalfampridinePosted: April 8, 2014
Dr. Channa Kolb, Assistant Professor of Neurology at UB, appears in a new, interactive, patient program for dalfampridine (Ampyra), a novel oral agent for multiple sclerosis. The videos focus on the dosage schedule, benefits and side effects of dalfampridine, as well as the agent’s mechanism of action. Dr. Kolb received her M.D. from the University at Buffalo School of Medicine and Biomedical Sciences, and as a student was awarded the American Academy of Neurology medical student prize for Excellence in Neurology. She trained at Cleveland Clinic in Florida and Brigham and Women’s Hospital in Boston prior to joining the UB faculty in 2012. Her clinical and research focus is multiple sclerosis.